Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co KGaA    FRE   DE0005785604

Real-time Quote. Real-time Tradegate - 02/28 12:00:08 pm
75.21 EUR   -0.29%
02/20DJFRESENIUS : 4Q 2016 -- Forecast
02/02 FRESENIUS : Initial conversion price of equity-neutral convertible b..
01/31 FRESENIUS : Helios closes acquisition of Quirónsalud
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Fresenius Sets Pricing On EUR500 Million 7-Year Bond At 4.25% Area

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/21/2012 | 01:24pm CET

("Fresenius Sets Pricing On EUR500M 7-Year Bond At 4.25% Area," at 1020 GMT, misstated the vehicle issuing the bond in the first paragraph. The correct version follows:)

-German medical care company Fresenius SE & CO. KGaA (>> Fresenius SE & Co KGaA) has set price guidance on its EUR500 million seven-year bond in the area of 4.25%, one of the banks on the deal said Wednesday.

The issue will be priced later Wednesday, and books on the deal are comfortably oversubscribed, said one of the banks on the deal. The issue was primarily targeted at retail accounts, which showed a good deal of interest, it added.

The bond will be used--among other corporate purposes--to fund the acquisition of hospital operator Damp Group, which Fresenius acquired in October 2011.

Expected ratings are Ba1 from Moody's Investors Service and BB+ from Standard & Poor's Corp. and Fitch Ratings.

Royal Bank of Scotland Group PLC, Deutsche Bank AG, Commerzbank AG, LBBW and Bayern LB are lead managers on the deal.

-By Serena Ruffoni, Dow Jones Newswires; +44 (0) 207 842 9349; serena.ruffoni@dowjones.com

Stocks mentioned in the article : Fresenius SE & Co KGaA
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS SE & CO KGAA
02/20DJFRESENIUS : 4Q 2016 -- Forecast
02/02 FRESENIUS : Initial conversion price of equity-neutral convertible bonds fixed
01/31 FRESENIUS : Helios closes acquisition of Quirónsalud
01/23 FRESENIUS : Denco Area 9-1-1 achieves CALEA accreditation
2016 DGAP-NVR : Fresenius SE & Co. KGaA: Veröffentlichung der Gesamtzahl der Stimmrec..
2016 DGAP-NVR : Fresenius SE & Co. KGaA: Release according to Article 26a of the WpHG..
2016 UNION PACIFIC : Emergency Response Communication Center Recognized for Excellenc..
2016 CIRCLE : Enters Rehabilitation Services Venture With VAMED
2016 DGAP-DD : Fresenius SE & Co. KGaA deutsch
2016 DGAP-DD : Fresenius SE & Co. KGaA english
More news
Sector news : Hospitals, Clinics & Primary Care Services
02/23DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare Swings to Net Loss in 4th Quarter..
02/23DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare Swings to Loss in 4th Quarter
02/22DJFRESENIUS MEDICAL CARE : Profit Lifted by Strong U.S. Performance
02/21 HSBC pulls FTSE lower
02/20DJFRESENIUS MEDICAL CARE : 4Q 2016 -- Forecast
More sector news : Hospitals, Clinics & Primary Care Services
News from SeekingAlpha
02/22 Fresenius' (FSNUY) CEO Stephan Sturm on Q4 2016 Results - Earnings Call Trans..
02/22 Fresenius SE & Co. KGaA ADR 2016 Q4 - Results - Earnings Call Slides
02/22 Fresenius SE & Co reports Q4 results
2016 HAEMONETICS : Investor Patience Is Wearing Thin
2016 Fresenius' (FSNUY) CEO Stephan Sturm on Q3 2016 Results - Earnings Call Trans..
Advertisement
Financials (€)
Sales 2017 33 664 M
EBIT 2017 4 981 M
Net income 2017 1 898 M
Debt 2017 15 932 M
Yield 2017 0,97%
P/E ratio 2017 22,08
P/E ratio 2018 19,95
EV / Sales 2017 1,71x
EV / Sales 2018 1,56x
Capitalization 41 745 M
More Financials
Chart FRESENIUS SE & CO KGAA
Duration : Period :
Fresenius SE & Co KGaA Technical Analysis Chart | FRE | DE0005785604 | 4-Traders
Full-screen chart
Technical analysis trends FRESENIUS SE & CO...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 80,3 €
Spread / Average Target 6,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stephan Sturm Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Niko Stumpfögger Member-Supervisory Board
Dario Anselmo Ilossi Member-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO KGAA1.58%44 238
IHH HEALTHCARE BHD--.--%10 889
RAMSAY HEALTH CARE LIM..1.54%10 865
BANGKOK DUSIT MEDICAL ..--.--%9 058
ENVISION HEALTHCARE CO..12.80%8 499
MEDICLINIC INTERNATION..-4.35%6 793
More Results